Literature DB >> 35988054

The effect of different SARS-CoV-2 variants.

Chi-Kuei Hsu1, Chih-Cheng Lai2.   

Abstract

Entities:  

Year:  2022        PMID: 35988054      PMCID: PMC9538714          DOI: 10.1002/alz.12766

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


× No keyword cloud information.
To the Editor We read with interest the retrospective cohort study by Wang et al., which assessed the association between COVID‐19 vaccination and the risk and the clinical outcomes of SARS‐CoV‐2 infection in a large population of older adults between December 2020 and August 2021. They found that compared to those without dementia, patients with dementia were associated increased risk of breakthrough infection in vaccinated populations. However, we have one serious concern about their findings. Although Wang et al. using the propensity score matching method to balance the demographic features of patients with and without dementia, the time variable was neglected. The epidemiology of SARS‐CoV‐2 had rapid evolutionary change since its first outbreak in Wuhan, China. In September 2020, the emergence of the first variants of concern (VOCs)—the alpha strain was identified in UK which was followed by several major concerns, including beta strain in South Africa in later September, gamma strain in Brazil in November 2020, delta strain in India in December 2020, omicron strain in South Africa in November 2021, that developed with time. , However, they have had various impacts on transmissibility, immunity, and severity. The alpha strain could increase transmissibility and severity, but it had drastically reduced circulation following the emergence of delta strain and vaccine induced immunity. By contrast, although omicron strain can increase transmissibility its association with COVID‐19 severity is reduced, which can be associated with a better clinical outcome, such as a lower risk of hospitalization and mortality. Moreover, the effect of COVID‐19 vaccine on different VOCs was not the same. During the study period, all these VOCs except omicron variant would be the major concerns. To overcome this confounding effect caused by SARS‐CoV‐2 variants, it is better to match the index date using the date of full vaccination.

CONFLICTS OF INTEREST

Author disclosures are available in the supporting information. Supporting Information Click here for additional data file.
  2 in total

1.  COVID-19 breakthrough infections and hospitalizations among vaccinated patients with dementia in the United States between December 2020 and August 2021.

Authors:  Lindsey Wang; Pamela B Davis; David C Kaelber; Rong Xu
Journal:  Alzheimers Dement       Date:  2022-04-13       Impact factor: 16.655

2.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.

Authors:  Chih-Cheng Lai; Tzu-Ping Shih; Wen-Chien Ko; Hung-Jen Tang; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2020-02-17       Impact factor: 5.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.